9101B |
Acepromazine Screen, Blood |
9101SP |
Acepromazine Screen, Serum/Plasma |
9101U |
Acepromazine Screen, Urine |
9105B |
Acetyl Fentanyl Screen, Blood |
9105SP |
Acetyl Fentanyl Screen, Serum/Plasma |
9105U |
Acetyl Fentanyl Screen, Urine |
9136B |
Chlorpromazine Screen, Blood |
9136SP |
Chlorpromazine Screen, Serum/Plasma |
9136U |
Chlorpromazine Screen, Urine |
9145UC |
Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9159B |
Disopyramide Screen, Blood |
9159SP |
Disopyramide Screen, Serum/Plasma |
9182B |
Haloperidol Screen, Blood |
9182SP |
Haloperidol Screen, Serum/Plasma |
9211B |
Mexiletine Screen, Blood |
9211SP |
Mexiletine Screen, Serum/Plasma |
9276B |
Thiothixene (Cis Isomer) Screen, Blood |
9276SP |
Thiothixene (Cis Isomer) Screen, Serum/Plasma |
9276U |
Thiothixene (Cis Isomer) Screen, Urine |
9329ME |
Benzodiazepines Panel (Qualitative), Meconium |
9351UC |
Basic Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9352UC |
Expanded Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9427B |
Thioridazine and Metabolite Screen, Blood |
9427SP |
Thioridazine and Metabolite Screen, Serum/Plasma |
9560B |
Synthetic Cannabinoids Screen, Blood |
9562U |
Synthetic Cannabinoid Metabolites Screen - Expanded, Urine |